Assessment of drugs in schizophrenia. Discussion on assessment of drug-induced extrapyramidal reactions.
作者信息
McClelland H A
出版信息
Br J Clin Pharmacol. 1976 Jun;3(3 Suppl 2):401-3. doi: 10.1111/j.1365-2125.1976.tb03733.x.
Abstract
摘要
相似文献
1
Assessment of drugs in schizophrenia. Discussion on assessment of drug-induced extrapyramidal reactions.精神分裂症药物评估。关于药物引起的锥体外系反应评估的讨论。
Br J Clin Pharmacol. 1976 Jun;3(3 Suppl 2):401-3. doi: 10.1111/j.1365-2125.1976.tb03733.x.
2
[Aspects of neuroleptic depot therapy with special consideration of clinical experiences with the preoral depot preparation Penfluridol (R 16 341-Jannsen)].
Int Pharmacopsychiatry. 1974;9(3):152-65.
3
Basic principles in the use of antipsychotic agents.
Hosp Community Psychiatry. 1973 Dec;24(12):825-9. doi: 10.1176/ps.24.12.825.
4
Drug-induced extrapyramidal side-effects in Egyptian schizophrenic patients.
Egypt J Psychiatry. 1979 Oct;2(2):191-7.
5
Dexetimide: an effective drug for the control of extrapyramidal symptoms induced by pipothiazine palmitate.
Acta Psychiatr Scand. 1973;49(5):563-9. doi: 10.1111/j.1600-0447.1973.tb04447.x.
6
Efficacy of antiparkinson agents in preventing antipsychotic-induced extrapyramidal symptoms.抗帕金森药物预防抗精神病药物所致锥体外系症状的疗效。
Am J Hosp Pharm. 1979 May;36(5):641-4.
7
Antiparkinsonian drugs in the treatment of neuroleptic-induced extrapyramidal symptoms.
Can J Psychiatry. 1994 Mar;39(2):74-84. doi: 10.1177/070674379403900203.
8
Drug-induced extrapyramidal syndromes.药物性锥体外系综合征
J R Coll Physicians Lond. 1970 Oct;5(1):87-98.
9
Some methodological considerations in the evaluation of drug-induced extrapyramidal disorders: a study of Ex10-029, a new morphanthridine derivative.
J Clin Pharmacol New Drugs. 1972 Apr;12(4):142-52. doi: 10.1002/j.1552-4604.1972.tb00043.x.
10
Treating extrapyramidal reactions: some current issues.治疗锥体外系反应：一些当前问题。
J Clin Psychiatry. 1987 Sep;48 Suppl:24-7.
引用本文的文献
1
A study of the early signs of drug induced parkinsonism.药物性帕金森综合征早期体征的研究。
J Neurol Neurosurg Psychiatry. 1993 Mar;56(3):301-3. doi: 10.1136/jnnp.56.3.301.
2
Neuroleptic-induced Parkinson's syndrome: clinical features and results of treatment with levodopa.抗精神病药物所致帕金森综合征：临床特征及左旋多巴治疗结果
J Neurol Neurosurg Psychiatry. 1988 Jun;51(6):850-4. doi: 10.1136/jnnp.51.6.850.
本文引用的文献
1
A survey of drug-induced extrapyramidal reactions.药物引起的锥体外系反应调查。
JAMA. 1961 Mar 25;175:1054-60. doi: 10.1001/jama.1961.03040120016004.
2
Extrapyramidal disorders after prolonged phenothiazine therapy.
Br J Psychiatry. 1971 May;118(546):509-18. doi: 10.1192/bjp.118.546.509.
3
Antiparkinsonian agents and depot phenothiazine.抗帕金森病药物和长效吩噻嗪类药物。
Am J Psychiatry. 1974 Jan;131(1):86-90. doi: 10.1176/ajp.131.1.86.
4
The side-effects of fluphenazine decanoate.
Br J Psychiatry. 1973 Nov;123(576):519-22. doi: 10.1192/bjp.123.5.519.
5
The abrupt withdrawal of antiparkinsonian drugs in schizophrenic patients.
Br J Psychiatry. 1974 Feb;124(579):151-9. doi: 10.1192/bjp.124.2.151.
6
Dopaminergic hypersensitivity and cholinergic hypofunction in the pathophysiology of tardive dyskinesia.迟发性运动障碍病理生理学中的多巴胺能超敏反应和胆碱能功能减退
Psychopharmacologia. 1974 Jan 9;34(1):21-35. doi: 10.1007/BF00421217.
7
Comparison of amantadine, orphenadrine, and placebo in the control of phenothiazine-induced Parkinsonism.
Psychol Med. 1972 Nov;2(4):406-13. doi: 10.1017/s0033291700045220.
8
Evaluating the long-term need for antiparkinson drugs by chronic schizophrenics.
Arch Gen Psychiatry. 1972 Apr;26(4):374-9. doi: 10.1001/archpsyc.1972.01750220084016.
9
Therapeutic approaches to tardive dyskinesia. A review of the literature.
Arch Gen Psychiatry. 1972 Oct;27(4):491-9. doi: 10.1001/archpsyc.1972.01750280059011.
10
Observations on the dose regime of fluphenazine decanoate in maintenance therapy ofschizophrenia.
Br J Psychiatry. 1975 May;126:457-61. doi: 10.1192/bjp.126.5.457.
Zotero 插件